Vigil Health Solutions Inc. (“Vigil”) announces
the results of operations for the quarter ending September 30,
2021.
Developments in the Quarter
- Revenue of $1.71
million up 24% from $1.37 in the three month period ended September
30, 2020.
- Earnings before
income taxes were $272 thousand up 31% from $208 thousand in the
three month period ended September 30, 2020.
- Sales bookings
for the quarter were $1.03 million compared to $1.57 million in the
three months ended September 30, 2020.
- Adjusted EBITDA
of $267 thousand compared to $259 thousand in the three months
ended September 30, 2020.
“We are pleased to see strong revenue and
earnings reflecting the continuity of service provided by Vigil
throughout the pandemic. Senior housing construction remains at the
low end of the business cycle and this is reflected in our second
quarter sales bookings. Senior living occupancy has shown some
recovery in recent quarters and while the immediate future
continues to have some uncertainty, we remain optimistic about the
senior living market in the longer term,” stated Troy Griffiths,
President and CEO of Vigil Health Solutions Inc.
Financial Results
Revenue for the three months ended September 30,
2021 was $1.71 million up 24% from $1.37 million in the three
months ended September 30, 2020. The increase in project revenue
reflects the completion of a $507 thousand project in the quarter.
Project revenue, includes new system installations and upgrades,
made up 53% of total revenue compared to 39% in the prior year. The
remaining revenue is from follow on one-off sales to existing
customers. These sales include software maintenance billings and
replacement products including wireless devices and communication
equipment.
Sales bookings for the quarter were $1.03
million compared to $1.57 million in the three months ended
September 30, 2020. There were 4 project bookings with an average
value of $64 thousand compared to 13 project bookings with an
average value of $61 thousand in the period ending September 30,
2020. The lower bookings reflect the decline in new construction.
Sales bookings include projects closed in the quarter and normally
not recognized in revenue until future periods and one-off sales
recognized in revenue in the current period.
At September 30, 2021, Vigil had a backlog of
approximately $2.65 million (including $1.38 million in deposits
and progress billings, recorded as deferred revenue on the balance
sheet) compared to approximately $3.99 million (including $2.01
million in deposits and progress billings, recorded as deferred
revenue on the balance sheet) at September 30, 2020. The COVID-19
pandemic caused multiple project delays in 2020 resulting in a
larger than normal backlog. The Company’s backlog is the total
estimated revenue for contracts which are signed and have not been
completed (and may not have commenced).
The gross margin percentage for the three months
ended September 30, 2021 was 45% compared to 53% for the three
months ended September 30, 2020. The decrease reflects the higher
amount of project sales relative to one off sales. Project revenue
includes lower margin components including travel, labour and
occasionally, third party contractor fees, the latter having little
mark up. Customers generally purchase these installation services
directly however, the quarter included material third party
contractor’s fees, which decreased overall margin.
Operating expenditures for the three months
ended September 30, 2020 were $530 thousand up 7% from $494
thousand for the period ended September 30, 2019. The increase
reflects the decline in Canada Emergency Wage Subsidy (CEWS)
received. In the three months ended September 30, 2021 the Company
received $47 thousand in CEWS payments, recorded as a reduction in
payroll expense, compared to $93 thousand received in the three
months ended September 30, 2020. The increase in payroll expense
was mitigated by the recognition of $35 thousand relating to an
agreement with the Government of Canada to provide funding for
specific research and development projects. There were also
increases in sales and marketing expenses as COVID-19 restrictions
on travel were relaxed.
Earnings before income taxes were $272 thousand
up 31% from $208 thousand in the three month period ended September
30, 2020. Net earnings and comprehensive income were $217 thousand
or $0.012 per share compared to $145 thousand or $0.008 per share
for the three month period ended September 30, 2020.
Detailed financial statements along with
Management Discussion and Analysis have been filed with SEDAR
(www.sedar.com).
Financial information will be mailed to entitled security
holders on November 30, 2021, or, upon notice to the Company,
entitled security holders may request a copy of financials in
advance.
Summary Financial Information
|
|
Three months ended |
|
Six months ended |
|
|
|
September 30, |
|
September 30, |
|
September 30, |
|
September 30, |
|
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
|
|
|
|
|
|
Revenue |
$ |
1,708,838 |
|
1,372,713 |
|
3,410,830 |
|
2,624,574 |
|
|
|
|
|
|
|
Cost of
sales |
|
939,770 |
|
645,521 |
|
1,769,446 |
|
1,227,456 |
|
|
|
|
|
|
|
Gross profit |
|
769,068 |
|
727,192 |
|
1,641,384 |
|
1,397,118 |
|
|
|
|
|
|
|
Expenses |
|
529,609 |
|
493,841 |
|
1,109,941 |
|
955,691 |
|
|
|
|
|
|
|
Earnings before the following
items |
|
239,459 |
|
233,351 |
|
531,443 |
|
441,427 |
|
|
|
|
|
|
|
Other income (expense) |
|
32,853 |
|
(25,638 |
) |
22,021 |
|
(62,099 |
) |
|
|
|
|
|
|
Earnings before income
taxes |
|
272,312 |
|
207,713 |
|
553,464 |
|
379,328 |
|
|
|
|
|
|
|
Income taxes |
|
(54,930 |
) |
(62,321 |
) |
(78,230 |
) |
(113,182 |
) |
|
|
|
|
|
|
Net earnings and comprehensive |
|
|
|
|
|
earnings for the period |
$ |
217,382 |
|
145,392 |
|
475,234 |
|
266,146 |
|
Non-IFRS Measure
For the three and six month periods ended September 30, 2021, we
are disclosing Adjusted EBITDA, a non-IFRS financial measure, as a
supplementary indicator of operating performance. We define
Adjusted EBITDA as net income before, interest excluding interest
relating to right of use asset for lease on the Company’s head
office, income taxes, amortization excluding amortization of right
of use asset for the lease on the Company’s head office, stock
based compensation and currency gains or losses including
derivative foreign exchange differences. We are presenting the
non-IFRS financial measure in our filings because we use it
internally to make strategic decisions, forecast future results and
to evaluate our performance and because we believe that our current
and potential investors and analysts use the measure to assess
current and future operating results and to make investment
decisions. It is a non-IFRS measure, may not be comparable to other
companies and it is not intended as a substitute for IFRS
measures.
Adjusted EBITDA Reconciliation
|
|
Three months ended |
|
Six months ended |
|
|
|
Sept 30, |
|
Sept 30, |
|
Sept 30, |
|
Sept 30, |
|
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
|
|
|
|
|
|
Income for the period |
$ |
217,382 |
|
145,392 |
|
475,234 |
|
266,146 |
|
|
|
|
|
|
|
Add / (deduct) |
|
|
|
|
|
Foreign exchange |
|
(16,907 |
) |
18,163 |
|
(1,585 |
) |
61,056 |
|
Change in fair value of derivative |
|
(5,495 |
) |
3,171 |
|
519 |
|
(4,790 |
) |
Interest |
|
(1,972 |
) |
(2,903 |
) |
(3,794 |
) |
(8,905 |
) |
Tax |
|
54,930 |
|
62,321 |
|
78,230 |
|
113,182 |
|
Share based payments |
|
11,115 |
|
21,434 |
|
23,563 |
|
34,146 |
|
Amortization |
|
7,926 |
|
11,221 |
|
15,462 |
|
22,456 |
|
|
|
49,597 |
|
113,407 |
|
112,395 |
|
217,145 |
|
|
|
|
|
|
|
Adjusted EBITDA |
$ |
266,979 |
|
258,799 |
|
587,629 |
|
483,291 |
|
About Vigil Health Solutions Inc.
Vigil offers a proprietary technology platform
combining software and hardware to provide comprehensive solutions
to the expanding seniors’ housing market. Vigil has established a
growing presence in North America and an international reputation
for being on the leading edge of systems design and integration.
Vigil’s objective is to offer solutions for the full continuum of
care. Vigil’s product range includes the innovative wireless
Vitality Care System™ featuring discreet 'mini pendants', a nurse
call system, mobile fall and incontinence monitoring, resident
check in and the award-winning Vigil Memory Care System.
Certain statements contained in this news
release that are not based on historical facts may constitute
forward-looking statements or forward-looking information within
the meaning of applicable securities laws (“forward-looking
statements”). These forward-looking statements are not promises or
guarantees of future performance but are only predictions that
relate to future events, conditions or circumstances or our future
results, performance, achievements or developments and are subject
to substantial known and unknown risks, assumptions, uncertainties
and other factors that could cause our actual results, performance,
achievements or developments in our business or in our industry to
differ materially from those expressed, anticipated or implied by
such forward-looking statements.
Forward-looking statements include all financial
guidance, disclosure regarding possible events, conditions,
circumstances, or results of operations that are based on
assumptions about future economic conditions, courses of action and
other future events. We caution you not to place undue reliance
upon any such forward-looking statements, which speak only as of
the date they are made. These forward-looking statements appear in
a number of different places in this presentation and can be
identified by words such as “may”, “estimates”, “projects”,
“expects”, “intends”, “believes”, “plans”, “anticipates”, or their
negatives or other comparable words. Forward-looking statements
include statements regarding the outlook for our future operations,
plans and timing for the introduction or enhancement of our
services and products, statements concerning strategies or
developments, statements about future market conditions, supply
conditions, end customer demand conditions, channel inventory and
sell through, revenue, gross margin, operating expenses, profits,
forecasts of future costs and expenditures, the outcome of legal
proceedings, and other expectations, intentions and plans that are
not historical fact.
The risk factors and uncertainties that may
affect our actual results, performance, achievements or
developments are many and include, amongst others, our ability to
develop our sales force and generate revenue, the length of the
sales cycle, management of the Company’s growth, ability to recruit
and retain staff, fluctuations in demand for current and future
products, our ability to develop, manufacture, supply and market
existing and new products that meet the needs of customers,
volatility in the exchange rate, ability to secure financing,
ability to secure product liability insurance, the continuous
commitment of our customers, increased competition, changes in
regulation and reliance on third party suppliers. These risk
factors and others, including the updated risks related to the
COVID-19 pandemic, are discussed in the Risks and Uncertainties
section of our “Management Discussion and Analysis” segment of our
fiscal 2020 Annual Report. Many of these factors and uncertainties
are beyond the control of the Company. Consequently, all
forward-looking statements in this news release are qualified by
this cautionary statement and there can be no assurance that actual
results, performance, achievements, or developments anticipated by
the Company will be realized.
We caution readers that the risks described are
not the only ones that could impact the Company. We cannot
accurately predict the full impact that COVID-19 will have on our
business, results of operations, financial condition or the demand
for our services, due in part to the uncertainties relating to the
ultimate geographic spread of the virus, the severity of the
disease, the duration of the outbreak, the steps our customers and
suppliers may take in current circumstances, including slowing or
halting operations, the duration of travel and quarantine
restrictions imposed by governments of affected countries and other
steps that may be taken by such governments to respond to the
pandemic. Additional risks and uncertainties not currently known to
us or that are currently deemed to be immaterial may also have a
material adverse effect on our business, financial condition, or
results of operations.
Forward-looking statements are based on
management’s current plans, estimates, projections, beliefs, and
opinions and, except as required by law, the Company does not
undertake any obligation to update forward-looking statements
should the assumptions related to these plans, estimates,
projections, beliefs, and opinions change.
For further information please contact:Troy Griffiths, President
and CEOTel: (250) 383-6900Fax: (250) 383-6999Email:
information@vigil.com |
Vigil Health Solutions Inc.2102-4464 Markham StreetVictoria, BCV8Z
7X8Website: www.vigil.com |
|
|
The TSX Venture Exchange has not reviewed and
does not accept responsibilityfor the adequacy or accuracy of this
release.
Vigil Health Solutions (TSXV:VGL)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Vigil Health Solutions (TSXV:VGL)
Historical Stock Chart
Von Dez 2023 bis Dez 2024